Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FV5DY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,786
Award facts
- Contract value 100% obligated
- $3,785.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,785.80 by the Defense Logistics Agency (DLA) on August 5, 2025, with an ultimate completion date of August 6, 2025. The delivery order, issued under a firm fixed-price contract type, covers the supply of Nucala 100 mg/ml auto-injector medication. This award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its small business status. The contract's place of performance is located in Park Ridge, Illinois, aligning with the vendor's headquarters location.
This delivery order represents a task issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and extending through November 2026. This overarching IDC establishes DMS Pharmaceutical Group as a key supplier of pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide, enabling the DLA to issue firm fixed-price delivery orders for a comprehensive range of medications, biologics, and specialty pharmaceutical items supporting military health system needs. The company's consistent procurement success with the DLA underscores its critical role in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FV5DY?
SPE2DB25FV5DY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FV5DY worth?
The government has obligated $3,786 on SPE2DB25FV5DY.
Is contract SPE2DB25FV5DY an order under another contract?
Yes. SPE2DB25FV5DY is a delivery order under SPE2DB22D9206, an indefinite delivery contract.
Was contract SPE2DB25FV5DY competed?
The extent of competition for SPE2DB25FV5DY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award